{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:39:18Z","timestamp":1790912358021,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11011-018-0344-x","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T15:32:12Z","timestamp":1542900732000},"page":"39-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review"],"prefix":"10.1007","volume":"34","author":[{"given":"Caren N\u00e1dia Soares","family":"de Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio Manuel Gon\u00e7alves","family":"da Silva Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingridy","family":"da Silva Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna Costa","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Moraes","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio Felipe Vasconcelos","family":"Patroc\u00ednio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna Let\u00edcia Vasconcelos","family":"Patroc\u00ednio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay\u00e7al","family":"Mouaffak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oussama","family":"Kebir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel Cl\u00e1udio Azevedo","family":"Patroc\u00ednio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e2nia Maria Mendes","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"344_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1001\/archinte.1959.00270050048008","volume":"103","author":"M Altschule","year":"1959","unstructured":"Altschule M, Goncz R, Holliday P (1959) Carbohydrate metabolism in brain disease. XI. Effects of thioctic (alpha-lipoic) acid in chronic schizophrenia. AMA Arch Intern Med 103:726\u2013729","journal-title":"AMA Arch Intern Med"},{"key":"344_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2011.566489","volume":"43","author":"DG Amen","year":"2011","unstructured":"Amen DG, Wu JC, Taylor D, Willeumier K (2011) Reversing brain damage in former NFL players: implications for traumatic brain injury and substance abuse rehabilitation. J Psychoactive Drugs 43:1\u20135. \n                    https:\/\/doi.org\/10.1080\/02791072.2011.566489","journal-title":"J Psychoactive Drugs"},{"key":"344_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/rej.2006.9.198","volume":"9","author":"P Arivazhagan","year":"2006","unstructured":"Arivazhagan P, Ayusawa D, Panneerselvam C (2006) Protective efficacy of \u03b1-lipoic acid on acetylcholinesterase activity in aged rat brain regions. Rejuvenation Res 9:198\u2013201. \n                    https:\/\/doi.org\/10.1089\/rej.2006.9.198","journal-title":"Rejuvenation Res"},{"key":"344_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/J.NUT.2017.09.011","volume":"47","author":"E Aubry","year":"2018","unstructured":"Aubry E, Aeberhard C, Bally L, Nuoffer JM, Risch L, M\u00fchlebach S, Burgunder JM, Stanga Z (2018) Are patients affected by mitochondrial disorders at nutritional risk? Nutrition 47:56\u201362. \n                    https:\/\/doi.org\/10.1016\/J.NUT.2017.09.011","journal-title":"Nutrition"},{"key":"344_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0306-3623(96)00474-0","volume":"29","author":"GP Biewenga","year":"1997","unstructured":"Biewenga GP, Haenen GRMM, Bast A (1997) The pharmacology of the antioxidant: lipoic acid. Gen Pharmacol 29:315\u2013331","journal-title":"Gen Pharmacol"},{"key":"344_CR6","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.neuroscience.2007.04.002","volume":"146","author":"A Bilska","year":"2007","unstructured":"Bilska A, Dubiel M, Soko\u0142owska-Jezewicz M et al (2007) Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brain. Neuroscience 146:1758\u20131771. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2007.04.002","journal-title":"Neuroscience"},{"issue":"21\u201326","key":"344_CR7","first-page":"6p","volume":"20","author":"V Bragin","year":"2005","unstructured":"Bragin V, Chemodanova M, Dzhafarova N et al (2005) Integrated treatment approach improves cognitive function in demented and clinically depressed patients. Am J Alzheimer\u2019s Dis Other Dementias 20(21\u201326):6p","journal-title":"Am J Alzheimer\u2019s Dis Other Dementias"},{"key":"344_CR8","doi-asserted-by":"publisher","unstructured":"Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG Jr, Renshaw PF, Cohen BM (2013) A placebo-controlled trial of acetyl-L-carnitine and \u03b1-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol. 33(5):627\u201335. \n                    https:\/\/doi.org\/10.1097\/JCP.0b013e31829a83f5","DOI":"10.1097\/JCP.0b013e31829a83f5"},{"key":"344_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.brainres.2008.11.025","volume":"1251","author":"HT Chng","year":"2009","unstructured":"Chng HT, New LS, Neo AH, Goh CW, Browne ER, Chan ECY (2009) Distribution study of orally administered lipoic acid in rat brain tissues. Brain Res 1251:80\u201386. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2008.11.025","journal-title":"Brain Res"},{"key":"344_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163484","volume":"11","author":"K-H Choi","year":"2016","unstructured":"Choi K-H, Park M-S, Kim J-T, Kim HS, Kim JH, Nam TS, Choi SM, Lee SH, Kim BC, Kim MK, Cho KH (2016) Lipoic acid use and functional outcomes after thrombolysis in patients with acute ischemic stroke and diabetes. PLoS One 11:e0163484. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0163484","journal-title":"PLoS One"},{"key":"344_CR11","first-page":"137","volume":"8","author":"D Cinteza","year":"2013","unstructured":"Cinteza D, Berteanu M, Vladoiu S, Manolescu BN, Dinu H (2013) The consumption of alanerv\u00ae nutritional supplement and the dynamic of some inflammatory markers in post-acute stroke patients undergoing rehabilitation. Maedica (Buchar) 8:137\u2013142","journal-title":"Maedica (Buchar)"},{"key":"344_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/adc.42.225.467","volume":"42","author":"BE Clayton","year":"1967","unstructured":"Clayton BE, Dobbs RH, Patrick AD (1967) Leigh\u2019s subacute necrotizing encephalopathy: clinical and biochemical study, with special reference to therapy with lipoate. Arch Dis Child 42:467\u2013478","journal-title":"Arch Dis Child"},{"key":"344_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrneurol.2010.147","volume":"6","author":"CS Constantinescu","year":"2010","unstructured":"Constantinescu CS, Gran B (2010) Multiple sclerosis: autoimmune associations in multiple sclerosis. Nat Rev Neurol 6:591\u2013592. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2010.147","journal-title":"Nat Rev Neurol"},{"key":"344_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/00207454.2010.535934","volume":"121","author":"DP Ara\u00fajo De","year":"2011","unstructured":"De Ara\u00fajo DP, Lobato RDFG, Cavalcanti JRLDP et al (2011) The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson\u2019s disease: a review. Int J Neurosci 121:51\u201357. \n                    https:\/\/doi.org\/10.3109\/00207454.2010.535934","journal-title":"Int J Neurosci"},{"key":"344_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12031-012-9884-4","volume":"50","author":"J Deslauriers","year":"2013","unstructured":"Deslauriers J, Desmarais C, Sarret P, Grignon S (2013) \u03b1-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt\/GSK-3\u03b2 signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia. J Mol Neurosci 50:134\u2013145. \n                    https:\/\/doi.org\/10.1007\/s12031-012-9884-4","journal-title":"J Mol Neurosci"},{"key":"344_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/WCO.0000000000000094","volume":"27","author":"R Dutta","year":"2014","unstructured":"Dutta R, Trapp BD (2014) Relapsing and progressive forms of multiple sclerosis: insights from pathology. Curr Opin Neurol 27:271\u2013278. \n                    https:\/\/doi.org\/10.1097\/WCO.0000000000000094","journal-title":"Curr Opin Neurol"},{"key":"344_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/J.SCHRES.2014.06.004","volume":"158","author":"R Emsley","year":"2014","unstructured":"Emsley R, Chiliza B, Asmal L, du Plessis S, Phahladira L, van Niekerk E, van Rensburg SJ, Harvey BH (2014) A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia. Schizophr Res 158:230\u2013235. \n                    https:\/\/doi.org\/10.1016\/J.SCHRES.2014.06.004","journal-title":"Schizophr Res"},{"key":"344_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neulet.2009.08.051","volume":"464","author":"PMP Ferreira","year":"2009","unstructured":"Ferreira PMP, Milit\u00e3o GCG, Freitas RM (2009) Lipoic acid effects on lipid peroxidation level, superoxide dismutase activity and monoamines concentration in rat hippocampus. Neurosci Lett 464:131\u2013134. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2009.08.051","journal-title":"Neurosci Lett"},{"key":"344_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jad.2014.10.010","volume":"172C","author":"EI Fried","year":"2014","unstructured":"Fried EI, Nesse RM (2014) Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J Affect Disord 172C:96\u2013102. \n                    https:\/\/doi.org\/10.1016\/j.jad.2014.10.010","journal-title":"J Affect Disord"},{"key":"344_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/207535a0","volume":"207","author":"EM Gal","year":"1965","unstructured":"Gal EM (1965) Reversal of selective toxicity of (\u2212)-\u03b1-lipoic acid by thiamine in thiamine-deficient rats. Nature 207:535","journal-title":"Nature"},{"key":"344_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/archneurol.2012.85","volume":"69","author":"DR Galasko","year":"2012","unstructured":"Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P, Alzheimer's Disease Cooperative Study (2012) Antioxidants for Alzheimer disease. Arch Neurol 69:836\u2013841. \n                    https:\/\/doi.org\/10.1001\/archneurol.2012.85","journal-title":"Arch Neurol"},{"key":"344_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1734-1140(11)70600-4","volume":"63","author":"A Gor\u0105ca","year":"2011","unstructured":"Gor\u0105ca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B (2011) Lipoic acid - biological activity and therapeutic potential. Pharmacol Rep 63:849\u2013858. \n                    https:\/\/doi.org\/10.1016\/S1734-1140(11)70600-4","journal-title":"Pharmacol Rep"},{"key":"344_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0167-4943(01)00104-2","volume":"32","author":"K Hager","year":"2001","unstructured":"Hager K, Marahrens A, Kenklies M, Riederer P, M\u00fcnch G (2001) Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia. Arch Gerontol Geriatr 32:275\u2013282","journal-title":"Arch Gerontol Geriatr"},{"key":"344_CR24","unstructured":"Hager K, Kenklies M, McAfoose J et al (2007) Alpha-lipoic acid as a new treatment option for Alzheimer\u2019s disease--a 48 months follow-up analysis. J Neural Transm Suppl:189\u2013193"},{"key":"344_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/CPAA.S71574","volume":"6","author":"R Hermann","year":"2014","unstructured":"Hermann R, Mungo J, Cnota PJ, Ziegler D (2014) Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms. Clin Pharmacol Adv Appl 6:195\u2013204. \n                    https:\/\/doi.org\/10.2147\/CPAA.S71574","journal-title":"Clin Pharmacol Adv Appl"},{"key":"344_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1674-6384(14)60051-4","volume":"90","author":"SD Holder","year":"2014","unstructured":"Holder SD, Wayhs A (2014) Schizophrenia. Am Fam Physician 90:775\u2013782. \n                    https:\/\/doi.org\/10.1016\/S1674-6384(14)60051-4","journal-title":"Am Fam Physician"},{"key":"344_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1034\/j.1399-5618.2000.020305.x","volume":"2","author":"T Kato","year":"2000","unstructured":"Kato T, Kato N (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2:180\u2013190","journal-title":"Bipolar Disord"},{"key":"344_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psc.2011.11.005","volume":"35","author":"RC Kessler","year":"2012","unstructured":"Kessler RC (2012) The costs of depression. Psychiatr Clin North Am 35:1\u201314. \n                    https:\/\/doi.org\/10.1016\/j.psc.2011.11.005","journal-title":"Psychiatr Clin North Am"},{"key":"344_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000356145","volume":"21","author":"M Khalili","year":"2014","unstructured":"Khalili M, Azimi A, Izadi V, Eghtesadi S, Mirshafiey A, Sahraian MA, Motevalian A, Norouzi A, Sanoobar M, Eskandari G, Farhoudi M, Amani F (2014a) Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial. Neuroimmunomodulation 21:291\u2013296. \n                    https:\/\/doi.org\/10.1159\/000356145","journal-title":"Neuroimmunomodulation"},{"key":"344_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1179\/1476830513Y.0000000060","volume":"17","author":"M Khalili","year":"2014","unstructured":"Khalili M, Eghtesadi S, Mirshafiey A, Eskandari G, Sanoobar M, Sahraian MA, Motevalian A, Norouzi A, Moftakhar S, Azimi A (2014b) Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial. Nutr Neurosci 17:16\u201320. \n                    https:\/\/doi.org\/10.1179\/1476830513Y.0000000060","journal-title":"Nutr Neurosci"},{"key":"344_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/JCP.0b013e31816777f7","volume":"28","author":"E Kim","year":"2008","unstructured":"Kim E, Park D-W, Choi S-H, Kim JJ, Cho HS (2008) A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia. J Clin Psychopharmacol 28:138\u2013146. \n                    https:\/\/doi.org\/10.1097\/JCP.0b013e31816777f7","journal-title":"J Clin Psychopharmacol"},{"key":"344_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/jnnp-2012-304601","volume":"86","author":"PN Leigh","year":"2015","unstructured":"Leigh PN, Al-Sarraj S, DiMauro S (2015) Impact commentaries. Subacute necrotising encephalomyelopathy (Leigh\u2019s disease; Leigh syndrome). J Neurol Neurosurg Psychiatry 86:363\u2013365. \n                    https:\/\/doi.org\/10.1136\/jnnp-2012-304601","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"344_CR33","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1007\/s12035-016-0079-9","volume":"54","author":"D Liu","year":"2017","unstructured":"Liu D, Ke Z, Luo J (2017) Thiamine deficiency and neurodegeneration: the interplay among oxidative stress, endoplasmic reticulum stress, and autophagy. Mol Neurobiol 54:5440\u20135448","journal-title":"Mol Neurobiol"},{"key":"344_CR34","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/ajmg.a.34114","volume":"155","author":"IT Lott","year":"2011","unstructured":"Lott IT, Doran E, Nguyen VQ, Tournay A, Head E, Gillen DL (2011) Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation. Am J Med Genet Part A 155:1939\u20131948. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.34114","journal-title":"Am J Med Genet Part A"},{"key":"344_CR35","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.addr.2008.04.015","volume":"60","author":"A Maczurek","year":"2008","unstructured":"Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, Carlson DA, M\u00fcnch G (2008) Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer\u2019s disease. Adv Drug Deliv Rev 60:1463\u20131470. \n                    https:\/\/doi.org\/10.1016\/j.addr.2008.04.015","journal-title":"Adv Drug Deliv Rev"},{"key":"344_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1526-4610.2006.00626.x","volume":"47","author":"D Magis","year":"2007","unstructured":"Magis D, Ambrosini A, S\u00e1ndor P, Jacquy J, Laloux P, Schoenen J (2007) A randomized double-blind placebo-controlled trial of Thioctic acid in migraine prophylaxis. Headache J Head Face Pain 47:52\u201357. \n                    https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00626.x","journal-title":"Headache J Head Face Pain"},{"key":"344_CR37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S1734-1140(13)71054-5","volume":"65","author":"BN Manolescu","year":"2013","unstructured":"Manolescu BN, Berteanu M, Cintez\u00e3 D (2013) Effect of the nutritional supplement ALAnerv\u00ae on the serum PON1 activity in post-acute stroke patients. Pharmacol Rep 65:743\u2013750","journal-title":"Pharmacol Rep"},{"key":"344_CR38","first-page":"248","volume":"9","author":"BN Manolescu","year":"2014","unstructured":"Manolescu BN, Cinteza D, Berteanu M, Busu C, Oprea E (2014) The relationship between alanerv(\u00ae) consumption and erythrocytes\u2019 redox status in post-acute stroke patients undergoing rehabilitation. Maedica (Buchar) 9:248\u2013254","journal-title":"Maedica (Buchar)"},{"key":"344_CR39","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336\u2013341. \n                    https:\/\/doi.org\/10.1016\/j.ijsu.2010.02.007","journal-title":"Int J Surg"},{"key":"344_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","volume":"45","author":"S Moylan","year":"2014","unstructured":"Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O\u2019Neil A, Hayley AC, Pasco JA, Anderson G, Jacka FN, Maes M (2014) Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 45:46\u201362. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2014.05.007","journal-title":"Neurosci Biobehav Rev"},{"key":"344_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1139\/apnm-2012-0436","volume":"38","author":"E Oprea","year":"2013","unstructured":"Oprea E, Berteanu M, Cintez\u00e3 D, Manolescu BN (2013) The effect of the ALAnerv nutritional supplement on some oxidative stress markers in postacute stroke patients undergoing rehabilitation. Appl Physiol Nutr Metab 38:613\u2013620. \n                    https:\/\/doi.org\/10.1139\/apnm-2012-0436","journal-title":"Appl Physiol Nutr Metab"},{"key":"344_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0006-2952(95)00116-H","volume":"50","author":"P Ou","year":"1995","unstructured":"Ou P, Tritschler HJ, Wolff SP (1995) Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 50:123\u2013126. \n                    https:\/\/doi.org\/10.1016\/0006-2952(95)00116-H","journal-title":"Biochem Pharmacol"},{"key":"344_CR43","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jama.2015.3058","volume":"313","author":"S Prabhakaran","year":"2015","unstructured":"Prabhakaran S, Ruff I, Bernstein RA (2015) Acute stroke intervention: a systematic review. JAMA. J Am Med Assoc 313:1451\u20131462","journal-title":"J Am Med Assoc"},{"key":"344_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3371\/CSRP.RAPA.030113","volume":"8","author":"JC Ratliff","year":"2015","unstructured":"Ratliff JC, Palmese LB, Reutenauer EL, Tek C (2015) An open-label pilot trial of alpha-lipoic acid for weight loss in patients with schizophrenia without diabetes. Clin Schizophr Relat Psychoses 8:196\u2013200. \n                    https:\/\/doi.org\/10.3371\/CSRP.RAPA.030113","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"344_CR45","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1177\/1535370215618462","volume":"241","author":"P Riccio","year":"2016","unstructured":"Riccio P, Rossano R, Larocca M, Trotta V, Mennella I, Vitaglione P, Ettorre M, Graverini A, de Santis A, di Monte E, Coniglio MG (2016) Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study. Exp Biol Med (Maywood) 241:620\u2013635. \n                    https:\/\/doi.org\/10.1177\/1535370215618462","journal-title":"Exp Biol Med (Maywood)"},{"key":"344_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mus.20688","volume":"35","author":"MC Rodriguez","year":"2007","unstructured":"Rodriguez MC, MacDonald JR, Mahoney DJ et al (2007) Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 35:235\u2013242. \n                    https:\/\/doi.org\/10.1002\/mus.20688","journal-title":"Muscle Nerve"},{"key":"344_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1212\/WNL.50.3.645","volume":"50","author":"N Sacktor","year":"1998","unstructured":"Sacktor N, Kieburtz K, Schifitto G et al (1998) A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Neurology 50:645\u2013651","journal-title":"Neurology"},{"key":"344_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013058","volume":"5","author":"S Salinthone","year":"2010","unstructured":"Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW (2010) Lipoic acid attenuates inflammation via cAMP and protein kinase a signaling. PLoS One 5:e13058. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0013058","journal-title":"PLoS One"},{"key":"344_CR49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/JCP.0000000000000800","volume":"37","author":"LLO Sanders","year":"2017","unstructured":"Sanders LLO, de Souza Menezes CE, Chaves Filho AJM, de Almeida Viana G, Fechine FV, Rodrigues de Queiroz MG, Gon\u00e7alvez da Cruz Fonseca S, Mendes Vasconcelos SM, Amaral de Moraes ME, Gama CS, Seybolt S, de Moura Campos E, Mac\u00eado D, Freitas de Lucena D (2017) \u03b1-Lipoic acid as adjunctive treatment for schizophrenia. J Clin Psychopharmacol 37:697\u2013701. \n                    https:\/\/doi.org\/10.1097\/JCP.0000000000000800","journal-title":"J Clin Psychopharmacol"},{"key":"344_CR50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1590\/S0004-282X2010000300006","volume":"68","author":"IMDS Santos","year":"2010","unstructured":"Santos IMDS, De FRLM, Saldanha GB et al (2010) Alterations on monoamines concentration in rat hippocampus produced by lipoic acid. Arq Neuropsiquiatr 68:362\u2013366. \n                    https:\/\/doi.org\/10.1590\/S0004-282X2010000300006","journal-title":"Arq Neuropsiquiatr"},{"key":"344_CR51","doi-asserted-by":"publisher","unstructured":"Schwedt TJ (2014) Chronic migraine. BMJ 348:g1416. doi: \n                    https:\/\/doi.org\/10.1136\/BMJ.G1416","DOI":"10.1136\/BMJ.G1416"},{"key":"344_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/JAD-130722","volume":"38","author":"L Shinto","year":"2014","unstructured":"Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J (2014) A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer\u2019s disease. J Alzheimers Dis 38:111\u2013120. \n                    https:\/\/doi.org\/10.3233\/JAD-130722","journal-title":"J Alzheimers Dis"},{"key":"344_CR53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00210-013-0867-y","volume":"386","author":"MCC Silva","year":"2013","unstructured":"Silva MCC, De Sousa CNS, Sampaio LRL et al (2013) Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression? Naunyn Schmiedeberg's Arch Pharmacol 386:685\u2013695. \n                    https:\/\/doi.org\/10.1007\/s00210-013-0867-y","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"344_CR54","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pnpbp.2015.08.002","volume":"64","author":"MCC Silva","year":"2016","unstructured":"Silva MCC, de Sousa CNS, Gomes PXL, de Oliveira GV, Ara\u00fajo FYR, Ximenes NC, da Silva JC, Silva Vasconcelos G, Leal LKAM, Mac\u00eado D, Vasconcelos SMM (2016) Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 64:142\u2013148. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2015.08.002","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"344_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/HTR.0b013e31823c0127","volume":"28","author":"N Smania","year":"2013","unstructured":"Smania N, Avesani R, Roncari L, Ianes P, Girardi P, Varalta V, Gambini MG, Fiaschi A, Gandolfi M (2013) Factors predicting functional and cognitive recovery following severe traumatic, anoxic, and cerebrovascular brain damage. J Head Trauma Rehabil 28:131\u2013140. \n                    https:\/\/doi.org\/10.1097\/HTR.0b013e31823c0127","journal-title":"J Head Trauma Rehabil"},{"key":"344_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/msj.20100","volume":"76","author":"CR Summers","year":"2009","unstructured":"Summers CR, Ivins B, Schwab KA (2009) Traumatic brain injury in the United States: an epidemiologic overview. Mt Sinai J med a J Transl. Pers Med 76:105\u2013110. \n                    https:\/\/doi.org\/10.1002\/msj.20100","journal-title":"Pers Med"},{"key":"344_CR57","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/0006-291X(92)90275-P","volume":"189","author":"YJ Suzuki","year":"1992","unstructured":"Suzuki YJ, Aggarwal BB, Packer L (1992) \u03b1-Lipoic acid is a potent inhibitor of NF-\u03baB activation in human T cells. Biochem Biophys Res Commun 189:1709\u20131715. \n                    https:\/\/doi.org\/10.1016\/0006-291X(92)90275-P","journal-title":"Biochem Biophys Res Commun"},{"key":"344_CR58","doi-asserted-by":"publisher","unstructured":"The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders (1998) A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in human immunodeficiency virus-associated cognitive impairment. Neurology 50:645\u2013651. \n                    https:\/\/doi.org\/10.1212\/WNL.50.3.645","DOI":"10.1212\/WNL.50.3.645"},{"key":"344_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nrneurol.2013.271","volume":"10","author":"M Tymianski","year":"2014","unstructured":"Tymianski M (2014) Stroke in 2013: disappointments and advances in acute stroke intervention. Nat Rev Neurol 10:66\u201368","journal-title":"Nat Rev Neurol"},{"key":"344_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.schres.2015.04.017","volume":"165","author":"GS Vasconcelos","year":"2015","unstructured":"Vasconcelos GS, Ximenes NC, de Sousa CNS, Oliveira TQ, Lima LLL, de Lucena DF, Gama CS, Mac\u00eado D, Vasconcelos SMM (2015) Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: participation of antioxidant, nitrergic and neurotrophic mechanisms. Schizophr Res 165:163\u2013170. \n                    https:\/\/doi.org\/10.1016\/j.schres.2015.04.017","journal-title":"Schizophr Res"},{"key":"344_CR61","first-page":"205","volume":"26","author":"B Vidovi\u0107","year":"2014","unstructured":"Vidovi\u0107 B, Milovanovi\u0107 S, Dor\u0111evi\u0107 B, Kotur-Stevuljevi\u0107 J, Stefanovi\u0107 A, Ivani\u0161evi\u0107 J, Miljkovi\u0107 M, Spasi\u0107 S, Stojanovi\u0107 D, Pantovi\u0107 M (2014) Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with schizophrenia. Psychiatr Danub 26:205\u2013213","journal-title":"Psychiatr Danub"},{"key":"344_CR62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jmf.2016.0070","volume":"20","author":"B Vidovi\u0107","year":"2017","unstructured":"Vidovi\u0107 B, Milovanovi\u0107 S, Stefanovi\u0107 A, Kotur-Stevuljevi\u0107 J, Taki\u0107 M, Debeljak-Marta\u010di\u0107 J, Pantovi\u0107 M, \u0110or\u0111evi\u0107 B (2017) Effects of alpha-lipoic acid supplementation on plasma adiponectin levels and some metabolic risk factors in patients with schizophrenia. J Med Food 20:79\u201385. \n                    https:\/\/doi.org\/10.1089\/jmf.2016.0070","journal-title":"J Med Food"},{"key":"344_CR63","unstructured":"WHO (2017) WHO | Dementia. In: WHO Dementia a public health priority"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-018-0344-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0344-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-018-0344-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:18:37Z","timestamp":1574363917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-018-0344-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["344"],"URL":"https:\/\/doi.org\/10.1007\/s11011-018-0344-x","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"assertion":[{"value":"7 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}